00979cam0-2200325---450-99000464136040332120080909100234.0000464136FED01000464136(Aleph)000464136FED0100046413619990604d1928----km-y0itay50------baitaITy-------001yy<<La >>vita e l'anima, la fantasia e l'arte dal Cinquecento al NovecentoAntonio FradelettoBariLaterza1928196 p.21 cmBiblioteca di cultura moderna166ArteStoriaSec. 16.-20.709.45709.03Fradeletto,Antonio<1858-1930>320001ITUNINARICAUNIMARCBK990004641360403321709.45 FRA 1Bibl.49180FLFBCFLFBCVita e l'anima, la fantasia e l'arte dal Cinquecento al Novecento554259UNINA02217nam 2200577 450 991077987300332120230803021102.01-78084-270-81-78084-271-6(CKB)2550000001101935(EBL)1179645(OCoLC)854971660(SSID)ssj0001599928(PQKBManifestationID)16306258(PQKBTitleCode)TC0001599928(PQKBWorkID)14892839(PQKB)11287715(MiAaPQ)EBC1179645(Au-PeEL)EBL1179645(EXLCZ)99255000000110193520220517d2013 uy 0engur|n|---|||||txtccrEmerging therapeutic options for hepatitis C /editors, Masao Omata, Tatsuo Kanda1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (117 p.)Description based upon print version of record.1-78084-272-4 Title page; Copyright page; Contents; Foreword. Hepatitis C virus infection: from discovery to eradication; 1. Interferons in clinical trials; 2. Protease inhibitors; 3. NS5A inhibitor: daclatasvir; 4. Toll-like receptor agonists for nonresponders to hepatitis C virus treatment: hope versus promise?; 5. Treatment options in HIV-HCV-coinfected patients; 6. Treatment options for dual hepatitis C/hepatitis B virus coinfection; 7. Hepatitis C virus treatment in patients with metabolic syndrome; 8. Future directions in hepatitis C therapy; IndexEmerging Therapeutic Options for Hepatitis CHepatitis CTreatmentHepatitis CChemotherapyAntiviral agentsHepatitis CTreatment.Hepatitis CChemotherapy.Antiviral agents.616.362306Omata MasaoKanda TatsuoMiAaPQMiAaPQMiAaPQBOOK9910779873003321Emerging therapeutic options for hepatitis C3763873UNINA